ANA Profile

The antinuclear antibody (ANA) profile is a blood test panel that screens for a group of autoantibodies associated with autoimmune conditions such as lupus, scleroderma, Sjogren's syndrome and mixed connective tissue disease. A positive ANA result indicates that the immune system may be producing antibodies against the body's own cells, prompting further specific antibody testing to pinpoint the exact condition. While a positive ANA can occur in healthy individuals, especially at low levels, higher titres combined with characteristic symptoms significantly raise suspicion for an underlying autoimmune disease. The panel is a key first step in the diagnostic workup for patients with unexplained multi-system symptoms suggestive of connective tissue disease.

ANA Profile is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Rheumatology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 24-48 hours for results. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes No recovery time is needed as this is a simple blood test. Patients can resume normal activities immediately after the sample is taken. Results are interpreted by a rheumatologist alongside clinical symptoms and additional specific antibody tests to reach a diagnosis.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

ANA Profile has a documented success rate of Highly sensitive for autoimmune screening at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.